George J. Todaro, MD
Affiliations: | National Cancer Institute, Rockville, MD, United States |
Google:
"George Todaro"Bio:
A 1963 Graduate of the NYU School of Medicine Honors Program, Todaro developed the 3T3 cell line in the laboratory of Howard Green and was later co-formulator of the oncogene hypothesis. Active with many notable achievements in the research of cell growth regulation and in the field of biotechnology, Todaro is a Professor of Pathobiology at the University of Washington. He also served as a Laboratory Chief at the National Cancer Institute of the National Institutes of Health and was elected to the National Academy of Sciences.
Cross-listing: Chemistry Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Twardzik DR, Todaro GJ. (1994) Methods for inhibiting neoplastic cell proliferation using platelet factor 4 Transfusion Science. 15 |
| Plowman GD, Green JM, McDonald VL, et al. (1990) The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Molecular and Cellular Biology. 10: 1969-81 |
| Shoyab M, McDonald VL, Byles C, et al. (1990) Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins. Proceedings of the National Academy of Sciences of the United States of America. 87: 7912-6 |
| Plowman GD, Whitney GS, Neubauer MG, et al. (1990) Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proceedings of the National Academy of Sciences of the United States of America. 87: 4905-9 |
| Horn D, Fitzpatrick WC, Gompper PT, et al. (1990) Regulation of cell growth by recombinant oncostatin M. Growth Factors (Chur, Switzerland). 2: 157-65 |
| Twardzik DR, Ranchalis JE, McPherson JM, et al. (1989) Inhibition and promotion of differentiated-like phenotype of a human lung carcinoma in athymic mice by natural and recombinant forms of transforming growth factor-beta. Journal of the National Cancer Institute. 81: 1182-5 |
| Twardzik DR, Ranchalis JE, Moss B, et al. (1987) Vaccinia growth factor: newest member of the family of growth modulators which utilize the membrane receptor for EGF. Acta Neurochirurgica. Supplementum. 41: 104-9 |
| Purchio AF, Twardzik DR, Bruce AG, et al. (1987) Synthesis of an active hybrid growth factor (GF) in bacteria: transforming GF-α/vaccinia GF fusion protein Gene. 60: 175-182 |
| Zarling JM, Shoyab M, Marquardt H, et al. (1986) Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America. 83: 9739-43 |
| Linsley PS, Hargreaves WR, Twardzik DR, et al. (1985) Detection of larger polypeptides structurally and functionally related to type I transforming growth factor. Proceedings of the National Academy of Sciences of the United States of America. 82: 356-60 |